CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: phosphoramidate ester
Accession: CHEBI:27577
browse the term
Definition: A phosphoric ester (phosphate) that has an NR2 instead of an OH group.
Synonyms: related_synonym: Phosphoamide; phosphoramidate esters
alt_id: CHEBI:26050; CHEBI:37718; CHEBI:8144
xref: KEGG:C01976
G
Ache
acetylcholinesterase
decreases activity multiple interactions
ISO EXP
fenamiphos results in decreased activity of ACHE protein fenamiphos binds to and results in increased phosphorylation of and results in decreased activity of ACHE protein
CTD
PMID:17382909 PMID:17402711 PMID:33720374
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Ar
androgen receptor
multiple interactions
ISO
fenamiphos inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]
CTD
PMID:33049310
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Esr1
estrogen receptor 1
multiple interactions
ISO
fenamiphos binds to and results in increased activity of ESR1 protein
CTD
PMID:33049310
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
multiple interactions
ISO
fenamiphos binds to and results in increased activity of ESR2 protein
CTD
PMID:33049310
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions affects activity
ISO
fenamiphos binds to and results in increased activity of NR1I2 protein fenamiphos affects the activity of NR1I2 protein
CTD
PMID:21115097 PMID:23611293 PMID:33049310
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions
ISO
fenamiphos binds to and results in increased activity of PPARG protein
CTD
PMID:33049310
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Tp53
tumor protein p53
affects activity
ISO
fenamiphos metabolite affects the activity of TP53 protein
CTD
PMID:35435491
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Cat
catalase
decreases activity multiple interactions
ISO EXP
propetamphos results in decreased activity of CAT protein [cypermethrin co-treated with propetamphos] results in decreased activity of CAT protein [propetamphos co-treated with cypermethrin] results in decreased activity of CAT protein
CTD
PMID:18214882 PMID:25926273
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cycs
cytochrome c, somatic
multiple interactions increases activity
EXP
[propetamphos co-treated with cypermethrin] results in increased activity of CYCS protein propetamphos results in increased activity of CYCS protein
CTD
PMID:25926273
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions increases activity
EXP
[cypermethrin co-treated with propetamphos] results in increased activity of CYP2E1 protein propetamphos results in increased activity of CYP2E1 protein
CTD
PMID:25926273
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
G6pd
glucose-6-phosphate dehydrogenase
multiple interactions decreases activity
EXP
[cypermethrin co-treated with propetamphos] results in decreased activity of G6PD protein propetamphos results in decreased activity of G6PD protein
CTD
PMID:25926273
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Tp53
tumor protein p53
affects activity
ISO
propetamphos metabolite affects the activity of TP53 protein
CTD
PMID:35435491
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Ache
acetylcholinesterase
increases hydrolysis
ISO
ACHE protein results in increased hydrolysis of remdesivir
CTD
PMID:34774545
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Atm
ATM serine/threonine kinase
increases phosphorylation
ISO
remdesivir results in increased phosphorylation of ATM protein
CTD
PMID:35417658
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
remdesivir results in increased expression of BAX protein
CTD
PMID:35417658
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bche
butyrylcholinesterase
increases hydrolysis
ISO
BCHE protein results in increased hydrolysis of remdesivir
CTD
PMID:34774545
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
remdesivir results in decreased expression of BCL2 protein
CTD
PMID:35417658
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l11
Bcl2-like 11
increases expression
ISO
remdesivir results in increased expression of BCL2L11 protein
CTD
PMID:35417658
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
G
Casp3
caspase 3
decreases expression
ISO
remdesivir results in decreased expression of CASP3 protein
CTD
PMID:35417658
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
decreases expression
ISO
remdesivir results in decreased expression of CASP7 protein
CTD
PMID:35417658
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Ccl2
C-C motif chemokine ligand 2
decreases expression
ISO
Remdesivir decreases expression of CCL2 mRNA and protein in SARS-CoV-2 induced hepatocellular carcinoma cells
RGD
PMID:32360580
RGD:30309211
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Cdx2
caudal type homeo box 2
increases expression
ISO
remdesivir results in increased expression of CDX2 mRNA
CTD
PMID:35605700
NCBI chr12:7,726,798...7,733,142
Ensembl chr12:7,726,798...7,733,142
G
Ces1d
carboxylesterase 1D
multiple interactions increases hydrolysis
ISO
Simvastatin inhibits the reaction [CES1 protein results in increased hydrolysis of remdesivir]
CTD
PMID:34774545
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
G
Ctsa
cathepsin A
increases hydrolysis
ISO
CTSA protein results in increased hydrolysis of remdesivir
CTD
PMID:34774545
NCBI chr 3:153,569,106...153,574,983
Ensembl chr 3:153,568,381...153,576,215
G
Cxcl10
C-X-C motif chemokine ligand 10
decreases expression
ISO
Remdesivir decreases expression of CXCL10 mRNA and protein in SARS-CoV-2 induced hepatocellular carcinoma cells
RGD
PMID:32360580
RGD:30309211
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Esrrb
estrogen-related receptor beta
decreases expression
ISO
remdesivir results in decreased expression of ESRRB mRNA
CTD
PMID:35605700
NCBI chr 6:106,007,701...106,163,136
Ensembl chr 6:106,008,095...106,160,791
G
Foxo3
forkhead box O3
increases expression
ISO
remdesivir results in increased expression of FOXO3 protein
CTD
PMID:35417658
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
G
Gata3
GATA binding protein 3
increases expression
ISO
remdesivir results in increased expression of GATA3 mRNA
CTD
PMID:35605700
NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391
G
Gata4
GATA binding protein 4
decreases expression
ISO
remdesivir results in decreased expression of GATA4 mRNA
CTD
PMID:35605700
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636
G
H2ax
H2A.X variant histone
increases expression
ISO
remdesivir results in increased expression of H2AX protein
CTD
PMID:35417658
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
G
Il1b
interleukin 1 beta
decreases expression
ISO
Remdesivir decreases expression of IL1B mRNA and protein in SARS-CoV-2 induced hepatocellular carcinoma cells
RGD
PMID:32360580
RGD:30309211
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
decreases expression
ISO
Remdesivir decreases expression of IL-6 mRNA and protein in SARS-CoV-2 induced hepatocellular carcinoma cells
RGD
PMID:32360580
RGD:30309211
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Mki67
marker of proliferation Ki-67
decreases expression
ISO
remdesivir results in decreased expression of MKI67 protein
CTD
PMID:35417658
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Nanog
Nanog homeobox
decreases expression
ISO
remdesivir results in decreased expression of NANOG mRNA
CTD
PMID:35605700
NCBI chr 4:155,943,737...155,951,116
Ensembl chr 4:155,943,737...155,951,116
G
Parp1
poly (ADP-ribose) polymerase 1
increases expression
ISO
remdesivir results in increased expression of PARP1 protein
CTD
PMID:35417658
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pdgfra
platelet derived growth factor receptor alpha
decreases expression
ISO
remdesivir results in decreased expression of PDGFRA mRNA
CTD
PMID:35605700
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
G
Sox17
SRY-box transcription factor 17
decreases expression
ISO
remdesivir results in decreased expression of SOX17 mRNA
CTD
PMID:35605700
NCBI chr 5:15,016,660...15,022,228
Ensembl chr 5:15,016,731...15,022,228
G
Sox2
SRY-box transcription factor 2
decreases expression
ISO
remdesivir results in decreased expression of SOX2 mRNA
CTD
PMID:35605700
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
G
Tnf
tumor necrosis factor
decreases expression
ISO
Remdesivir decreases expression of TNF mRNA and protein in SARS-CoV-2 induced hepatocellular carcinoma cells
RGD
PMID:32360580
RGD:30309211
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Klrc1
killer cell lectin like receptor C1
decreases expression
ISO
sofosbuvir co-treated with ledipasvir decreased expression of NCR1 protein in natural killer cells
RGD
PMID:31218578
RGD:40400920
NCBI chr 4:163,142,142...163,152,425
Ensembl chr 4:163,147,189...163,152,425
G
Ncr1
natural cytotoxicity triggering receptor 1
affects expression
ISO
sofosbuvir co-treated with ledipasvir affects expression of NCR1 protein in natural killer cells
RGD
PMID:31218578
RGD:40400920
NCBI chr 1:69,614,744...69,622,594
Ensembl chr 1:69,616,601...69,660,558
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all